Advertisement

Pediatric Cardiology

, Volume 39, Issue 7, pp 1476–1483 | Cite as

Longitudinal Outcomes of Epicardial and Endocardial Pacemaker Leads in the Adult Fontan Patient

  • Geoffrey D. Huntley
  • Abhishek J. Deshmukh
  • Carole A. Warnes
  • Suraj Kapa
  • Alexander C. Egbe
Original Article

Abstract

Placement of an epicardial pacemaker system is often preferred over an endocardial system in patients who have undergone a Fontan operation, but data are limited on how these two systems perform over time in patients with Fontan palliation. We performed a retrospective review of adults with Fontan palliation who had pacemaker implantation and interrogation data at Mayo Clinic from 1994 to 2014. Lead parameters, pacing mode, and polarity were collected at the earliest device interrogation report. Clinic notes and device interrogation reports were reviewed at implantation, 6 months, and yearly after implantation to determine impedance, capture threshold (CT), and energy threshold (ET). There were 87 patients with 168 leads in the study cohort. The mean follow-up time was 7.7 years (6 months–19 years). There were 143 epicardial leads (57 atrial and 86 ventricular) and 25 endocardial leads (20 atrial and 5 ventricular). There was no difference in the baseline lead parameters between epicardial and endocardial leads for impedance (610 ± 259 versus 583 ± 156 Ω, p = 0.93), CT (2.0 ± 1.3 versus 1.8 ± 1.3 V, p = 0.28), or ET (7.1 ± 12.5 versus 6.8 ± 18.1 µJ, p = 0.29). Compared to endocardial leads, ventricular epicardial leads were associated with temporal decrease in impedance and increase in ET. Regarding clinical outcomes, epicardial leads had higher rates of failure but similar generator longevity in comparison to endocardial leads. Ventricular epicardial leads were associated with temporal decrease in impedance and increase in ET. Epicardial leads had a higher rate of failure but similar generator longevity compared to endocardial leads.

Keywords

Fontan palliation Adult congenital heart disease Pacemaker Epicardial leads Transvenous leads Capture threshold 

Notes

Author Contributions

GDH contributed to concept/design, data analysis/interpretation, drafting article, and statistics. AJD contributed to concept/design and critical revision of article. CAW contributed to concept/design and approval of article. SK contributed to concept/design and critical revision of article. ACE contributed to concept/design, data interpretation, drafting article, and critical revision of article.

Compliance with Ethical Standards

Conflict of interest

The authors have no conflicts of interest.

References

  1. 1.
    Nakano T, Kado H, Tatewaki H, Hinokiyama K, Oda S, Ushinohama H, Sagawa K, Nakamura M, Fusazaki N, Ishikawa S (2015) Results of extracardiac conduit total cavopulmonary connection in 500 patients. Eur J Cardiothorac Surg 48(6):825–832.  https://doi.org/10.1093/ejcts/ezv072 (discussion 832)CrossRefPubMedGoogle Scholar
  2. 2.
    Iyengar AJ, Winlaw DS, Galati JC, Wheaton GR, Gentles TL, Grigg LE, Justo RN, Radford DJ, Weintraub RG, Bullock A, Celermajer DS, d’Udekem Y (2014) The extracardiac conduit Fontan procedure in Australia and New Zealand: hypoplastic left heart syndrome predicts worse early and late outcomes. Eur J Cardiothorac Surg 46(3):465–473.  https://doi.org/10.1093/ejcts/ezu015 (discussion 473)CrossRefPubMedGoogle Scholar
  3. 3.
    Ono M, Kasnar-Samprec J, Hager A, Cleuziou J, Burri M, Langenbach C, Callegari A, Strbad M, Vogt M, Horer J, Schreiber C, Lange R (2016) Clinical outcome following total cavopulmonary connection: a 20-year single-centre experience. Eur J Cardiothorac Surg 50(4):632–641.  https://doi.org/10.1093/ejcts/ezw091 CrossRefPubMedGoogle Scholar
  4. 4.
    Pundi KN, Johnson JN, Dearani JA, Li Z, Hinck CA, Dahl SH, Cannon BC, O’Leary PW, Driscoll DJ, Cetta F (2015) 40-year follow-up after the Fontan operation: long-term outcomes of 1,052 patients. J Am Coll Cardiol 66(15):1700–1710.  https://doi.org/10.1016/j.jacc.2015.07.065 CrossRefPubMedGoogle Scholar
  5. 5.
    Dabal RJ, Kirklin JK, Kukreja M, Brown RN, Cleveland DC, Eddins MC, Lau Y (2014) The modern Fontan operation shows no increase in mortality out to 20 years: a new paradigm. J Thorac Cardiovasc Surg 148(6):2517–2523 e2511.  https://doi.org/10.1016/j.jtcvs.2014.07.075 CrossRefPubMedGoogle Scholar
  6. 6.
    Tweddell JS, Nersesian M, Mussatto KA, Nugent M, Simpson P, Mitchell ME, Ghanayem NS, Pelech AN, Marla R, Hoffman GM (2009) Fontan palliation in the modern era: factors impacting mortality and morbidity. Ann Thorac Surg 88(4):1291–1299.  https://doi.org/10.1016/j.athoracsur.2009.05.076 CrossRefPubMedGoogle Scholar
  7. 7.
    Egbe AC, Connolly HM, Dearani JA, Bonnichsen CR, Niaz T, Allison TG, Johnson JN, Poterucha JT, Said SM, Ammash NM (2016) When is the right time for Fontan conversion? The role of cardiopulmonary exercise test. Int J Cardiol 220:564–568.  https://doi.org/10.1016/j.ijcard.2016.06.209 CrossRefPubMedGoogle Scholar
  8. 8.
    Said SM, Burkhart HM, Schaff HV, Cetta F, Driscoll DJ, Li Z, Oliver WC Jr, Ammash NM, Dearani JA (2014) Fontan conversion: identifying the high-risk patient. Ann Thorac Surg 97(6):2115–2121.  https://doi.org/10.1016/j.athoracsur.2014.01.083 (discussion 2121–2112)CrossRefPubMedGoogle Scholar
  9. 9.
    Williams MR, Shepard SM, Boramanand NK, Lamberti JJ, Perry JC (2014) Long-term follow-up shows excellent transmural atrial lead performance in patients with complex congenital heart disease. Circ Arrhythm Electrophysiol 7(4):652–657.  https://doi.org/10.1161/CIRCEP.113.001321 CrossRefPubMedGoogle Scholar
  10. 10.
    Walker F, Siu SC, Woods S, Cameron DA, Webb GD, Harris L (2004) Long-term outcomes of cardiac pacing in adults with congenital heart disease. J Am Coll Cardiol 43(10):1894–1901.  https://doi.org/10.1016/j.jacc.2003.12.044 CrossRefPubMedGoogle Scholar
  11. 11.
    Serwer GA, Mericle JM, Armstrong BE (1988) Epicardial ventricular pacemaker electrode longevity in children. Am J Cardiol 61(1):104–106CrossRefGoogle Scholar
  12. 12.
    Lau KC, William Gaynor J, Fuller SM, Karen AS, Shah MJ (2015) Long-term atrial and ventricular epicardial pacemaker lead survival after cardiac operations in pediatric patients with congenital heart disease. Heart Rhythm 12(3):566–573.  https://doi.org/10.1016/j.hrthm.2014.12.001 CrossRefPubMedGoogle Scholar
  13. 13.
    McLeod CJ, Attenhofer Jost CH, Warnes CA, Hodge D 2nd, Hyberger L, Connolly HM, Asirvatham SJ, Dearani JA, Hayes DL, Ammash NM (2010) Epicardial versus endocardial permanent pacing in adults with congenital heart disease. J Interv Card Electrophysiol 28(3):235–243.  https://doi.org/10.1007/s10840-010-9494-4 CrossRefPubMedGoogle Scholar
  14. 14.
    Ramesh V, Gaynor JW, Shah MJ, Wieand TS, Spray TL, Vetter VL, Rhodes LA (1999) Comparison of left and right atrial epicardial pacing in patients with congenital heart disease. Ann Thorac Surg 68(6):2314–2319CrossRefGoogle Scholar
  15. 15.
    Silvetti MS, Drago F, Di Carlo D, Placidi S, Brancaccio G, Carotti A (2013) Cardiac pacing in paediatric patients with congenital heart defects: transvenous or epicardial? Europace 15(9):1280–1286.  https://doi.org/10.1093/europace/eut029 CrossRefPubMedGoogle Scholar
  16. 16.
    Taliercio CP, Vlietstra RE, McGoon MD, Porter CJ, Osborn MJ, Danielson GK (1985) Permanent cardiac pacing after the Fontan procedure. J Thorac Cardiovasc Surg 90(3):414–419PubMedGoogle Scholar
  17. 17.
    Takahashi K, Cecchin F, Fortescue E, Berul CI, Alexander ME, Walsh EP, Fynn-Thompson F, Triedman JK (2009) Permanent atrial pacing lead implant route after Fontan operation. Pacing Clin Electrophysiol 32(6):779–785.  https://doi.org/10.1111/j.1540-8159.2009.02365.x CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Cohen MI, Vetter VL, Wernovsky G, Bush DM, Gaynor JW, Iyer VR, Spray TL, Tanel RE, Rhodes LA (2001) Epicardial pacemaker implantation and follow-up in patients with a single ventricle after the Fontan operation. J Thorac Cardiovasc Surg 121(4):804–811.  https://doi.org/10.1067/mtc.2001.113027 CrossRefPubMedGoogle Scholar
  19. 19.
    Shah MJ, Nehgme R, Carboni M, Murphy JD (2004) Endocardial atrial pacing lead implantation and midterm follow-up in young patients with sinus node dysfunction after the Fontan procedure. Pacing Clin Electrophysiol 27(7):949–954.  https://doi.org/10.1111/j.1540-8159.2004.00564.x CrossRefPubMedGoogle Scholar
  20. 20.
    Janson CM, Patel AR, Bonney WJ, Smoots K, Shah MJ (2014) Implantable cardioverter-defibrillator lead failure in children and young adults: a matter of lead diameter or lead design? J Am Coll Cardiol 63(2):133–140.  https://doi.org/10.1016/j.jacc.2013.09.033 CrossRefPubMedGoogle Scholar
  21. 21.
    Hamilton RM, Chiu C, Gow RM, Williams WG (1997) A comparison of two stab-on unipolar epicardial pacing leads in children. Pacing Clin Electrophysiol 20(3 Pt 1):631–636CrossRefGoogle Scholar
  22. 22.
    Esperer HD, Singer H, Riede FT, Blum U, Mahmoud FO, Weniger J (1993) Permanent epicardial and transvenous single- and dual-chamber cardiac pacing in children. Thorac Cardiovasc Surg 41(1):21–27.  https://doi.org/10.1055/s-2007-1013815 CrossRefPubMedGoogle Scholar
  23. 23.
    Silka MJ, Rice MJ (1991) Paradoxic embolism due to altered hemodynamic sequencing following transvenous pacing. Pacing Clin Electrophysiol 14(4 Pt 1):499–503CrossRefGoogle Scholar
  24. 24.
    Gillette PC, Zeigler V, Bradham GB, Kinsella P (1988) Pediatric transvenous pacing: a concern for venous thrombosis? Pacing Clin Electrophysiol 11(11 Pt 2):1935–1939CrossRefGoogle Scholar
  25. 25.
    Fortescue EB, Berul CI, Cecchin F, Walsh EP, Triedman JK, Alexander ME (2004) Patient, procedural, and hardware factors associated with pacemaker lead failures in pediatrics and congenital heart disease. Heart Rhythm 1(2):150–159.  https://doi.org/10.1016/j.hrthm.2004.02.020 CrossRefPubMedGoogle Scholar
  26. 26.
    Zhang T, Liu Y, Zou C, Zhang H (2016) Single chamber permanent epicardial pacing for children with congenital heart disease after surgical repair. J Cardiothorac Surg 11(1):61.  https://doi.org/10.1186/s13019-016-0439-6 CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Cohen MI, Bush DM, Vetter VL, Tanel RE, Wieand TS, Gaynor JW, Rhodes LA (2001) Permanent epicardial pacing in pediatric patients: seventeen years of experience and 1200 outpatient visits. Circulation 103(21):2585–2590CrossRefGoogle Scholar
  28. 28.
    Silvetti MS, Drago F, Grutter G, De Santis A, Di Ciommo V, Rava L (2006) Twenty years of paediatric cardiac pacing: 515 pacemakers and 480 leads implanted in 292 patients. Europace 8(7):530–536.  https://doi.org/10.1093/europace/eul062 CrossRefPubMedGoogle Scholar
  29. 29.
    Sachweh JS, Vazquez-Jimenez JF, Schondube FA, Daebritz SH, Dorge H, Muhler EG, Messmer BJ (2000) Twenty years experience with pediatric pacing: epicardial and transvenous stimulation. Eur J Cardiothorac Surg 17(4):455–461CrossRefGoogle Scholar
  30. 30.
    Noiseux N, Khairy P, Fournier A, Vobecky SJ (2004) Thirty years of experience with epicardial pacing in children. Cardiol Young 14(5):512–519.  https://doi.org/10.1017/S1047951104005086 CrossRefPubMedGoogle Scholar
  31. 31.
    Egbe AC, Huntley GD, Connolly HM, Ammash NM, Deshmukh AJ, Khan AR, Said SM, Akintoye E, Warnes CA, Kapa S (2017) Outcomes of cardiac pacing in adult patients after a Fontan operation. Am Heart J 194:92–98.  https://doi.org/10.1016/j.ahj.2017.08.019 CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Geoffrey D. Huntley
    • 1
  • Abhishek J. Deshmukh
    • 2
  • Carole A. Warnes
    • 2
  • Suraj Kapa
    • 2
  • Alexander C. Egbe
    • 2
  1. 1.School of MedicineMayo ClinicRochesterUSA
  2. 2.Department of Cardiovascular DiseasesMayo ClinicRochesterUSA

Personalised recommendations